| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0026-0495(88)90023-6 |
| P698 | PubMed publication ID | 3275857 |
| P50 | author | Lawrence J Mandarino | Q91188766 |
| John E. Gerich | Q112187461 | ||
| P2093 | author name string | Campbell PJ | |
| P2860 | cites work | Insulin Sensitivity and Insulin Binding to Monocytes in Maturity-Onset Diabetes | Q37038173 |
| P433 | issue | 1 | |
| P921 | main subject | Glucose | Q37525 |
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 15-21 | |
| P577 | publication date | 1988-01-01 | |
| P1433 | published in | Metabolism | Q15764354 |
| P1476 | title | Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. | |
| P478 | volume | 37 |
| Q36646317 | 31st g. Heiner sell lectureship: secondary medical consequences of spinal cord injury |
| Q48009194 | Alteration in immunoexpression of glucose transporter 2 in liver of tumour-bearing rats |
| Q58782434 | Anthropometric cutoffs and associations with visceral adiposity and metabolic biomarkers after spinal cord injury |
| Q37190820 | Application of network construction to estimate functional changes to insulin receptor substrates 1 and 2 in Huh7 cells following infection with the hepatitis C virus |
| Q35824548 | Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q51585232 | Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus. |
| Q40955178 | Central Regulation of Glucose Production May Be Impaired in Type 2 Diabetes |
| Q44074164 | Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects |
| Q51578716 | Comparison of hyperinsulinaemic clamp experiments using venous, 'arterialized' venous or capillary euglycaemia. |
| Q35074878 | Computational assessment of insulin secretion and insulin sensitivity from 2-h oral glucose tolerance tests for clinical use for type 2 diabetes |
| Q51615494 | Contribution of gluconeogenesis to overall glucose output in diabetic and nondiabetic men. |
| Q54248122 | Contribution of glucose/glucose 6-phosphate cycle activity to insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus. |
| Q37052621 | Coronary heart disease in individuals with spinal cord injury: assessment of risk factors |
| Q34253010 | Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance |
| Q42278739 | Effect of Short-term Erythropoietin Therapy on Insulin Resistance and Serum Levels of Leptin and Neuropeptide Y in Hemodialysis Patients |
| Q73384092 | Effects of endothelin-1 and nitric oxide on glucokinase activity in isolated rat hepatocytes |
| Q36867037 | Effects of insulin and the combination of insulin plus metformin (glucophage) on microvascular reactivity in control and diabetic hamsters |
| Q40961991 | Effects of insulin on glucose turnover rates in vivo: isotope dilution versus constant specific activity technique |
| Q51559853 | Ethnicity affects the postprandial regulation of glycogenolysis. |
| Q43512312 | Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus |
| Q47325031 | Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen |
| Q30466963 | Hepatic glucose metabolism and insulin resistance in NIDDM and obesity |
| Q35505394 | Hepatitis C virus infection: molecular pathways to insulin resistance |
| Q72795603 | How to measure insulin action in vivo |
| Q72534738 | Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats |
| Q46635801 | Improved insulin action following short-term exercise training: role of energy and carbohydrate balance |
| Q51568464 | Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model. |
| Q35596356 | Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus |
| Q37341813 | Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals |
| Q51563266 | Influence of streptozotocin-induced diabetes in rats on the lithium content of tissue and the effect of dietary lithium supplements on this diabetic condition. |
| Q51304272 | Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. |
| Q46890714 | Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome |
| Q36297331 | Insulin resistance: a metabolic pathway to chronic liver disease |
| Q39304941 | Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH. |
| Q37723462 | Insulin therapy in maturity-onset diabetes |
| Q60044878 | Insulin translates unfavourable lifestyle into obesity |
| Q35612844 | Insulin-like growth factor-I improves glucose and lipid metabolism in type 2 diabetes mellitus |
| Q37444351 | Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? |
| Q98164482 | Mathematical model of blood glucose dynamics by emulating the pathophysiology of glucose metabolism in type 2 diabetes mellitus |
| Q35818094 | Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism |
| Q35148800 | Metabolic and molecular basis of insulin resistance |
| Q43206333 | Metformin regulates palmitate-induced apoptosis and ER stress response in HepG2 liver cells |
| Q38628354 | Molecular pathophysiology of hepatic glucose production |
| Q51613996 | On the determination of basal glucose production rate in patients with type 2 (non-insulin-dependent) diabetes mellitus using primed-continuous 3-3H-glucose infusion. |
| Q41037864 | On the interplay between insulin secretion and sensitivity as determinants of glucose tolerance |
| Q51595607 | Overnight glucose metabolism in obese non-insulin-dependent diabetic patients and in healthy lean individuals. |
| Q34237562 | Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy |
| Q35787142 | Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview |
| Q68168637 | Perioperative Management of the Diabetic Patient |
| Q44655640 | Pharmacokinetics and anti‐hyperglycaemic efficacy of a novel inhibitor of glycogen phosphorylase, 1,4‐dideoxy‐1,4‐imino‐d‐ arabinitol, in glucagon‐challenged rats and dogs and in diabetic ob/ob mice |
| Q27307174 | Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys |
| Q87663139 | Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome |
| Q35180118 | Postprandial whole-body glycolysis is similar in insulin-resistant and insulin-sensitive non-diabetic humans |
| Q39578344 | Role of insulin resistance in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus |
| Q35188665 | The acute effects of HIV protease inhibitors on insulin suppression of glucose production in healthy HIV-negative men. |
| Q71482506 | The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus |
| Q51597848 | The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes. |
| Q34201786 | The effects of non-insulin-dependent diabetes mellitus on the kinetics of onset of insulin action in hepatic and extrahepatic tissues |
| Q40521981 | The fourth musketeer--from Alexandre Dumas to Claude Bernard |
| Q40945389 | The genetics and pathophysiology of type II and gestational diabetes |
| Q40973181 | The role of intracellular Ca2+ in the regulation of gluconeogenesis |
| Q68026986 | Twenty-four-hour energy expenditure in Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus |
| Q35136669 | Urinary C-peptide excretion: a novel alternate measure of insulin sensitivity in physiological conditions |
| Q47318452 | Weight gain and insulin requirement in type 2 diabetic patients during the first year after initiating insulin therapy dependent on baseline BMI. |
Search more.